Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02363907 · ClinicalTrials.gov registry record
Observational Study to Evaluate the Effectiveness and Safety of the Dexcom G4 Continuous Glucose Monitoring System in Pediatrics
A clinical trial of Diabetes Mellitus, sponsored by DexCom.
- Completed
- Registry status
- 30
- Enrollment target
- 1
- Study location
NCT02363907: Completed study of Diabetes Mellitus, sponsored by DexCom.
NCT02363907 is a study of Diabetes Mellitus that has completed, run by DexCom. The registered enrollment target is 30 participants, below the 1,867-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02363907, a study of Diabetes Mellitus, has completed, sponsored by DexCom.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate the effectiveness and safety of the Dexcom G4 System when used as an adjuvant to blood glucose testing over a 7-day period in people 2 to 17 years-old with diabetes mellitus.
Primary Outcome
"Point Accuracy was evaluated in terms of the percentage of CGM values that were within ±20% of glucose meter reference value for glucose levels \>80 mg/dL and ±20 mg/dL of glucose meter reference values for glucose levels \<80 mg/dL
Conditions Studied
Study Locations (1)
Idaho
- Rocky Mountain Diabetes and Osteoporosis Center - Idaho Falls
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2012-09 |
| Est. Completion | 2012-10 |
What the finished NCT02363907 record still lists
NCT02363907 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,867-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Diabetes Mellitus appearing as the primary indexed condition, and to 0 interventions.
NCT02363907 reports a single indexed study location in Idaho.
Frequently Asked Questions
What is clinical trial NCT02363907 about?
NCT02363907 is a clinical study titled "Observational Study to Evaluate the Effectiveness and Safety of the Dexcom G4 Continuous Glucose Monitoring System in Pediatrics". The purpose of this study is to evaluate the effectiveness and safety of the Dexcom G4 System when used as an adjuvant to blood glucose testing over a 7-day period in people 2 to 17 years-old with diabetes mellitus.
What is the current status of trial NCT02363907?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2012-09. Estimated completion is 2012-10.
What conditions does trial NCT02363907 study?
This clinical trial studies the following conditions: Diabetes Mellitus.
Who is sponsoring clinical trial NCT02363907?
This trial is sponsored by DexCom, which has 26 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02363907 being conducted?
This trial has 1 study location across Idaho. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes Mellitus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02363907's enrollment target sits among peer trials
30 177th of 208 higher than 29 of 208 other Diabetes Mellitus trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diabetes Mellitus trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Genetic Studies of Insulin and Diabetes
RECRUITING
-
Improving Glycemic Control With Telemedicine and Smart Insulin Pens
RECRUITING · NA
-
Family Investigation of Nephropathy and Diabetes (F.I.N.D.)
RECRUITING
-
Genetics Of Autoimmunity In Type I Diabetes
RECRUITING
-
Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older Adults
RECRUITING · NA
-
Therapeutic Plantar Electrical Stimulation Intervention During Hemodialysis to Improve Balance and Mobility
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia